What does IMTB mean in MEDICAL
Institut of Molecular Tumor Biology (IMTB) is an interdisciplinary research center devoted to the study of cancer involving molecules and the development of new treatments targeted at the molecular level. IMTB was established by the German Federal Ministry of Education and Research (BMBF) in 2005, with the goal of combining expertise in molecular tumor biology from multiple disciplines including biochemistry, genetics, pharmacology, histopathology, and clinical oncology. The main focus of the institute is to gain a better understanding how tumor cells grow and divide, what triggers their abnormal behavior, why they evade immunologic control, and how we can target them more effectively for treatment. IMTB is part of the German Cancer Consortium (DKTK) which is a network that functions like an umbrella organization for several leading research institutions in Germany to promote cooperation in cancer research.
IMTB meaning in Medical in Medical
IMTB mostly used in an acronym Medical in Category Medical that means Institut of Molecular Tumor Biology
Shorthand: IMTB,
Full Form: Institut of Molecular Tumor Biology
For more information of "Institut of Molecular Tumor Biology", see the section below.
What does IMTB Stand For?
IMTB stands for Institut of Molecular Tumor Biology. IMTB is a research center dedicated to studying different aspects related to cancer on a molecular level. The institute works towards gaining knowledge about why tumor cells behave abnormally and how they can be effectively targeted for removal or treatment.
What Does IMTB Mean in MEDICAL?
IMTB stands for Institut of Molecular Tumor Biology and refers to an institute that focuses on researching all aspects related to cancer involving molecules. The institute's core mission revolves around furthering our understanding regarding how tumor cells divide, how they are able to evade immune control mechanisms, as well as exploring new avenues through which we can target these cells more effectively.
Essential Questions and Answers on Institut of Molecular Tumor Biology in "MEDICAL»MEDICAL"
What is the Institute of Molecular Tumor Biology?
The Institute of Molecular Tumor Biology (IMTB) at the Charité - Universitätsmedizin Berlin is an interdisciplinary research institute for tumor biology. It focuses on innovative basic and translational cancer research, with the aim to develop novel therapeutic strategies and diagnostics.
What types of cancer research does IMTB conduct?
IMTB conducts cutting-edge cancer research in areas such as epigenomics, regulatory networks for immune cells in tumors, cancer microenvironment, and mechanobiology. It uses a versatile set of methods to identify key players and underlying mechanisms that are important for tumor initiation, progression, dissemination or successful treatment.
Who works at IMTB?
IMTB is composed of over 50 scientists from a wide range of academic backgrounds including immunologists, virologists, biophysicists, geneticists and molecular biologists. Among them are 16 group leaders that offer several postdoctoral and PhD positions every year.
Does IMTB accept applications from members outside its Institute?
Yes. Scientists interested in joining the institute can apply for postdoctoral or PhD positions provided by the group leaders through the websites of Charité - Universitätsmedizin Berlin or through collaboration networks like EU-LIFE.
What resources does IMTB provide to its researchers?
IMTB's researchers have access to state-of-the-art equipment and core facilities including flow cytometry cell sorting machine, high throughput imaging system (HTIS), electron microscope imaging system (EMIS), bioimaging facility (BIF). In addition, they can use various highly specialized technologies such as advanced molecular analysis platforms like mass spectrometry systems or gene expression profiling services like RNAseq.
Does IMTB collaborate with external organizations?
Yes. The institute regularly collaborates with national institutions and international organisations to promote its scientific activities and share knowledge in the field of tumor biology research globally. Collaborations involve both public & private partners from all over Europe such as universities, clinical centers or industry partners e.g., pharmaceutical companies.
Final Words:
In conclusion, IMTB stands for Institut of Molecular Tumor Biology – an interdisciplinary research institution devoted to investigating various facets associated with cancer on a molecular level. Through its work, it hopes to gain better insights into how cancerous cells behave abnormally and develop effective therapies targeting them directly. Ultimately, this could help provide improved survival rates amongst patients suffering from terminal illnesses due to cancerous tumours.